Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study.
about
Public health and international drug policy.Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012.Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugsCommentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.More than just someone to inject drugs with: Injecting within primary injection partnerships.HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Utilization of buprenorphine and methadone among opioid users who inject drugs.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic.HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.Injecting drug use in low and middle-income countries: Opportunities to improve care and prevent harm.Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies.Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.HCV reinfection incidence among individuals treated for recent infection.Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection.Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks.'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Harm Reduction: Front Line Public Health.A prospective study of hepatitis C incidence in Australian prisoners.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.'Sussing that doctor out.' Experiences and perspectives of people affected by hepatitis C regarding engagement with private general practitioners in South Australia: a qualitative study.Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs.Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 CollaborationImpact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
P2860
Q30377895-36CD81FB-E8FA-4FFF-891F-92E3500DBE50Q35551683-B04311D5-F7C8-4AB6-AB2D-DB0954887895Q35581138-A3A1EF84-7824-4CB8-BED8-535294519EECQ35690302-3E672F36-3454-4018-8374-F54F045EFDBCQ35703205-1675668B-4FE6-4BC5-9740-2B6E7655A4A5Q35817533-ACBAD20F-B23E-42A5-AA8B-ABDFD1F49745Q35889562-B250AA6F-D48E-4C0A-971A-AD67FB93D2A7Q35903698-8E15A145-0385-4637-A389-1E3D1B3D27A3Q36108046-E69E710B-B175-482B-814B-480F3A5802B9Q36248999-8907FC0C-705D-4CA1-B2D2-FBCB952D0349Q36506119-372ABD65-3E55-4599-8C2B-B7E5E1541AA1Q38613271-150A15C3-FF59-4737-85EB-A170C9AA77E2Q38630550-9CCDD22E-1696-457F-8B8E-544F83BB3813Q38661825-CA173EA3-9769-4F72-BCDE-291EB39851E0Q38666907-759F3E71-135D-4ED7-87D1-48C490FC85D9Q38692113-D8E122A4-B21C-46A7-B89F-1E4D0325276DQ38717150-49BFB6B4-BB55-4DF5-A746-6BD7A6930BFEQ38931620-F7D2B762-00C1-43CF-8386-8CAE8E91559DQ39123236-0A317BD5-7C1C-4B8F-8EFF-E23E0205E57BQ39157096-4BA3F40F-E61A-490D-8D34-7668BED3AF6BQ40048259-D2F66297-46C1-48A0-A3C0-A87C8A1946FCQ40092669-9F96A79C-B86C-4E4A-B294-1641610E5149Q40118634-02C97934-8662-45BF-8B0C-54EFE6F242EAQ40393982-E8988205-9597-4E25-A043-22A8A7AC2EBCQ40563923-3B2A8BA0-D65A-4B6D-9A13-E0656D84A7B3Q40637053-66C07365-56B8-4711-A529-501568059FAAQ40694556-8E571E10-6E5B-4535-8ABD-2FB13F16BEA7Q41047662-16A09D19-C1E3-4022-B803-70A019FA1FE9Q41157775-73987EFA-0584-4BE1-BEFD-82D292E71293Q42213249-CCFDBC26-301D-492B-BD3A-E4D1E44CD0B6Q42720607-3DBC74CD-D92B-46B6-9947-DDDB8DCAE624Q47156419-CDBC8809-69C1-4F5B-A1BB-8469C84AF994Q47579352-3C85E546-3269-4AE9-9A07-4492C6D32843Q54636663-BFA6C701-FFEE-439C-9C6B-2CBD725F1DBBQ56556912-C56B7FAD-A367-4EFA-841D-367B826E9D3AQ57700826-49D0F2B5-6D0C-44A1-BBB7-274902218D61
P2860
Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Opioid substitution therapy pr ...... nject drugs: the HITS-c study.
@en
type
label
Opioid substitution therapy pr ...... nject drugs: the HITS-c study.
@en
prefLabel
Opioid substitution therapy pr ...... nject drugs: the HITS-c study.
@en
P50
P356
P1476
Opioid substitution therapy pr ...... nject drugs: the HITS-c study.
@en
P2093
Gregory J Dore
P304
P356
10.5694/MJA13.00153
P407
P577
2014-09-01T00:00:00Z